Follow
Kathleen Sheehan
Kathleen Sheehan
Professor of Pathology and Immunology, Washington University School of Medicine in St. Louis
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK–STAT signaling pathway
MA Meraz, JM White, KCF Sheehan, EA Bach, SJ Rodig, AS Dighe, ...
Cell 84 (3), 431-442, 1996
20581996
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
SJ Rodig, MA Meraz, JM White, PA Lampe, JK Riley, CD Arthur, KL King, ...
Cell 93 (3), 373-383, 1998
11161998
Persistent LCMV infection is controlled by blockade of type I interferon signaling
JR Teijaro, C Ng, AM Lee, BM Sullivan, KCF Sheehan, M Welch, ...
Science 340 (6129), 207-211, 2013
8522013
Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
SL Erickson, FJ De Sauvage, K Kikly, K Carver-Moore, S Pitts-Meek, ...
Nature 372 (6506), 560-563, 1994
7291994
A critical function for type I interferons in cancer immunoediting
GP Dunn, AT Bruce, KCF Sheehan, V Shankaran, R Uppaluri, JD Bui, ...
Nature immunology 6 (7), 722-729, 2005
7172005
MHC-II neoantigens shape tumour immunity and response to immunotherapy
E Alspach, DM Lussier, AP Miceli, I Kizhvatov, M DuPage, AM Luoma, ...
Nature 574 (7780), 696-701, 2019
6392019
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
KC Sheehan, NH Ruddle, RD Schreiber
Journal of immunology (Baltimore, Md.: 1950) 142 (11), 3884-3893, 1989
5111989
Type I IFN contributes to NK cell homeostasis, activation, and antitumor function
JB Swann, Y Hayakawa, N Zerafa, KCF Sheehan, B Scott, RD Schreiber, ...
The Journal of Immunology 178 (12), 7540-7549, 2007
3732007
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity
JE Fenner, R Starr, AL Cornish, JG Zhang, D Metcalf, RD Schreiber, ...
Nature immunology 7 (1), 33-39, 2006
3622006
High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy
MM Gubin, E Esaulova, JP Ward, ON Malkova, D Runci, P Wong, ...
Cell 175 (4), 1014-1030. e19, 2018
3502018
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.
GJ Bancroft, KC Sheehan, RD Schreiber, ER Unanue
Journal of immunology (Baltimore, Md.: 1950) 143 (1), 127-130, 1989
3351989
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
3312020
Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation
C Ferran, K Sheehan, M Dy, R Schreiber, S Merite, P Landais, LH Noel, ...
European journal of immunology 20 (3), 509-515, 1990
3221990
Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids
C Paget, T Mallevaey, AO Speak, D Torres, J Fontaine, KCF Sheehan, ...
Immunity 27 (4), 597-609, 2007
3202007
Blocking Monoclonal Antibodies Specific for Mouse IFN-α/β Receptor Subunit 1 (IFNAR-1) from Mice Immunized by In Vivo Hydrodynamic Transfection
KCF Sheehan, KS Lai, GP Dunn, AT Bruce, MS Diamond, JD Heutel, ...
Journal of interferon & cytokine research 26 (11), 804-819, 2006
2732006
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression
GP Dunn, KCF Sheehan, LJ Old, RD Schreiber
Cancer research 65 (8), 3447-3453, 2005
2142005
Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
KC Sheehan, JK Pinckard, CD Arthur, LP Dehner, DV Goeddel, ...
The Journal of experimental medicine 181 (2), 607-617, 1995
1981995
Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation
A Krug, R Uppaluri, F Facchetti, BG Dorner, KCF Sheehan, RD Schreiber, ...
The Journal of Immunology 169 (11), 6079-6083, 2002
1972002
Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection
CT Ng, BM Sullivan, JR Teijaro, AM Lee, M Welch, S Rice, KCF Sheehan, ...
Cell host & microbe 17 (5), 653-661, 2015
1792015
Interferon-γ and cancer immunoediting
GP Dunn, H Ikeda, AT Bruce, C Koebel, R Uppaluri, J Bui, R Chan, ...
Immunologic research 32, 231-245, 2005
1762005
The system can't perform the operation now. Try again later.
Articles 1–20